Michael R O'Sullivan
Nursing at Magnolia St, Denver, CO

License number
Colorado 702895
Issued Date
Jul 29, 2003
Renew Date
Feb 1, 2004
Expiration Date
Jan 31, 2006
Type
Certified Nurse Aide
Address
Address
1731 S Magnolia St, Denver, CO 80224

Professional information

Michael O'Sullivan Photo 1

Michael O'sullivan - Denver, CO

Work:
Select Energy Services
Project Manager
UNITED STATES MARINE CORPS
Second Lieutenant
PHOENIX COYOTES - Phoenix, AZ
Group Sales Account Executive
ANGELS BASEBALL - Anaheim, CA
Inside Sales Executive
UC SANTA BARBARA INTERCOLLEGIATE ATHLETICS OFFICE - Santa Barbara, CA UC SANTA BARBARA INTERCOLLEGIATE ATHLETICS OFFICE - Santa Barbara, CA
Ticket Sales/Event Operations
Education:
UNIVERSITY OF CALIFORNIA - Quantico, VA
Bachelor of Science in Physical Anthropology
EL TORO HIGH SCHOOL - Lake Forest, CA
High School Diploma in Activities


Michael O'Sullivan Photo 2

Michael O'sullivan - Denver, CO

Work:
United States Marine Corps
Second Lieutenant
Phoenix Coyotes
Account Executive
Angels Baseball - Anaheim, CA
Inside Sales Representative
UC Santa Barbara Library
Associate
UC Santa Barbara Intercollegiate Athletics Office
Ticket Sales Representative
Disneyland California
Attractions Attendant
Education:
University of California Santa Barbara - Santa Barbara, CA
BS in Physical Anthropology
El Toro High School


Michael O'Sullivan Photo 3

Piperidine-Containing Compounds And Use Thereof

US Patent:
2011027, Nov 10, 2011
Filed:
Jan 7, 2010
Appl. No.:
13/143998
Inventors:
Martha E. Rodriguez - Boulder CO, US
David A. Mareska - Boulder CO, US
Jeremy J. Hans - Saint Louis MO, US
Darren M. Harvey - Boulder CO, US
Robert D. Groneberg - Boulder CO, US
Michael O'Sullivan - Denver CO, US
Assignee:
ARRAY BIOPHARMA INC. - Boulder CO
International Classification:
A61K 31/454, C07D 417/14, C07D 413/14, C07D 409/06, C07D 417/06, C07D 401/06, A61K 31/4535, C07D 409/14, A61K 31/4725, C07D 471/04, A61K 31/437, C07D 498/04, A61K 31/5025, A61K 31/506, A61K 31/496, A61K 31/5377, A61P 3/10, C07D 413/06
US Classification:
5142102, 546209, 514326, 546201, 514323, 514318, 546194, 546213, 546211, 546141, 514309, 546113, 514300, 544236, 514248, 544324, 514275, 544364, 5142531, 544130, 5142368
Abstract:
A method for preventing and/or treating a metabolic disease, cerebrovascular disease, etc. which comprises administering to a mammal an effective amount of the compound of the formula (I):wherein all symbols have the same meanings as defined in the specification; a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof. And a novel compound of the formula (I-1):wherein all symbols have the same meanings as defined in the specification; a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof has an anti-diabetic effect and a neuroprotective effect. Accordingly, the compound of the formula (I) and the compound of the formula (I-1) are useful in a method for preventing and/or treating for a metabolic disease such as diabetes, cerebrovascular disease such as stroke, etc.